Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayumi Maeda, M.D.

Concepts (65)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesia, Obstetrical320231692.310 Why?
Analgesia, Epidural320233322.060 Why?
Labor Pain12023150.860 Why?
Bupivacaine120234110.690 Why?
Analgesia120234610.620 Why?
Anesthetics, Local120239980.540 Why?
Delivery, Obstetric220239410.260 Why?
Pregnancy Outcome1201429230.220 Why?
Pregnancy82023298930.200 Why?
Spinal Puncture120232820.190 Why?
Opioid-Related Disorders2201721640.180 Why?
Pregnancy Complications1201429490.180 Why?
Parity120239290.170 Why?
Cesarean Section2201713990.140 Why?
Analgesics1202310680.130 Why?
Bradycardia120162980.120 Why?
Pregnancy Complications, Cardiovascular220165130.110 Why?
Pain Measurement1202335490.110 Why?
Obstetric Labor Complications120142360.100 Why?
Calcium Channel Blockers120156910.100 Why?
Maternal Mortality120143010.100 Why?
Placenta Accreta120152370.090 Why?
Infant, Newborn, Diseases120165890.090 Why?
Adrenergic beta-Antagonists1201612410.090 Why?
Fetal Diseases120159120.090 Why?
Maternal Exposure1201610670.080 Why?
Hypoglycemia120168830.080 Why?
Pain1202350720.080 Why?
Pain, Postoperative1201717410.070 Why?
Female820233925520.060 Why?
Seizures1201529650.050 Why?
Insurance, Health1201424930.050 Why?
Quality of Life12023133670.050 Why?
Time Factors12023399570.050 Why?
Analgesics, Opioid1201738050.050 Why?
Socioeconomic Factors1201478040.050 Why?
Humans820237612220.040 Why?
Prospective Studies12023544370.040 Why?
Adult520232211200.040 Why?
Hypertension2201685360.040 Why?
Prevalence12014157210.040 Why?
Labetalol12016290.030 Why?
Treatment Outcome12023646810.030 Why?
Atenolol12016990.030 Why?
Metoprolol12016900.030 Why?
Cesarean Section, Repeat12015280.030 Why?
United States42017723410.030 Why?
Retrospective Studies12023806750.030 Why?
Pregnancy Trimester, Third120155830.030 Why?
Postoperative Complications12015156370.030 Why?
Maternal Health Services120174600.020 Why?
Hypertension, Pregnancy-Induced120165180.020 Why?
Interviews as Topic1201726970.020 Why?
Propensity Score1201619160.020 Why?
Young Adult12014592220.020 Why?
Adolescent12014883000.020 Why?
Antihypertensive Agents1201520190.020 Why?
Infant, Newborn22016262000.020 Why?
Prenatal Exposure Delayed Effects1201525170.010 Why?
Databases, Factual1201579650.010 Why?
Incidence12015213660.010 Why?
Risk Assessment12015240220.010 Why?
Cohort Studies12016414960.010 Why?
Risk Factors12015742410.000 Why?
Male120163607030.000 Why?
Maeda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.